-transparent.png){kind=logo}
A single capsule of sustained release pseudoephedrine (SUDAFED S.A., Burroughs Wellcome Co.) was shown by objective and subjective measurements to be superior to placebo in relieving nasal congestion associated with allergic rhinitis. The drug had no discernible effect on (1) the degree of wetness perceived in the mouth or nose, (2) a complex of symptoms which included sneezing, coughing, sniffing, swallowing, itching of eyes and nose or (3) number of nose blows. The study was marked by an absence of serious adverse reactions.
Related Publications
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
March 1995,
The Nurse practitioner,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
January 1995,
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
January 1988,
The Journal of international medical research,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
May 2006,
Expert opinion on pharmacotherapy,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
September 1994,
The Medical letter on drugs and therapeutics,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
January 2006,
Asian Pacific journal of allergy and immunology,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
April 2000,
Ear, nose, & throat journal,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
February 2006,
Archives of otolaryngology--head & neck surgery,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
February 1998,
British journal of clinical pharmacology,
L H Hamilton, and
S L Chobanian, and
A Cato, and
J G Perkins
July 2006,
Expert review of clinical immunology,
